2009-12-03 : Neurology Kobelt G, Kasteng F. The burden of Multiple Sclerosis and access to innovative treatments in Europe. A report. www.comparatorreports.se. |
2009-10-12 : Rheumatology Kobelt G, Kasteng F. The burden of Rheumatoid Arthritis and access to innovative treatments in Europe. A Report. www.comparatorreports.se |
2009-09-21 : Rheumatology Kobelt G, Lindgren P, Geborek P. Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data. Scand J Rheumatol 2009;38:409-419 |
2009-06-01 : Neurology Kobelt.G, Texier-Richard B, Lindgren P. The longterm cost of multiple sclerosis in France and potential changes with disease modifying agents. Multiple Sclerosis 2009;15:741-751 |
2009-05-01 : Ophthalmology The cost of treating glaucoma with prostaglandins in France: a 4-year follow-up in routine clinical practice. |
2009-03-01 : Rheumatology Lindgren P, Kobelt G. Modelling the cost of rituximab in Sweden. Int J Technol Assess Health Care 2009;2:181-189 |